NasdaqGM - Delayed Quote USD

Avadel Pharmaceuticals plc (AVDL)

17.33 -0.05 (-0.29%)
At close: 4:00 PM EDT
17.33 0.00 (0.00%)
After hours: 5:34 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
27,963.00
27,963.00
--
--
22,334.00
Cost of Revenue
846.00
846.00
--
--
5,742.00
Gross Profit
27,117.00
27,117.00
--
--
16,592.00
Operating Expense
164,966.00
164,966.00
95,216.00
85,599.00
53,253.00
Operating Income
-137,849.00
-137,849.00
-95,216.00
-85,599.00
-36,661.00
Net Non Operating Interest Income Expense
-9,886.00
-9,886.00
-12,342.00
-9,942.00
-12,994.00
Other Income Expense
-13,042.00
-13,042.00
-3,881.00
2,396.00
44,573.00
Pretax Income
-160,777.00
-160,777.00
-111,439.00
-93,145.00
-5,082.00
Tax Provision
-501.00
-501.00
26,025.00
-15,816.00
-12,110.00
Net Income Common Stockholders
-160,276.00
-160,276.00
-137,464.00
-77,329.00
7,028.00
Diluted NI Available to Com Stockholders
-160,276.00
-160,276.00
-137,464.00
-77,329.00
7,028.00
Basic EPS
-2.00
--
-2.29
-1.32
0.13
Diluted EPS
-2.00
--
-2.29
-1.32
0.13
Basic Average Shares
80,174.00
--
60,094.00
58,535.00
52,996.00
Diluted Average Shares
80,174.00
--
60,094.00
58,535.00
54,941.00
Total Operating Income as Reported
-137,849.00
-137,849.00
-98,561.00
-85,546.00
5,815.00
Total Expenses
165,812.00
165,812.00
95,216.00
85,599.00
58,995.00
Net Income from Continuing & Discontinued Operation
-160,276.00
-160,276.00
-137,464.00
-77,329.00
7,028.00
Normalized Income
-147,273.13
-147,273.13
-134,398.01
-79,318.16
-23,054.57
Interest Expense
9,886.00
9,886.00
12,342.00
9,942.00
12,994.00
Net Interest Income
-9,886.00
-9,886.00
-12,342.00
-9,942.00
-12,994.00
EBIT
-150,891.00
-150,891.00
-99,097.00
-83,203.00
7,912.00
EBITDA
-149,125.00
-149,125.00
-97,604.00
-82,388.00
9,602.00
Reconciled Cost of Revenue
846.00
846.00
--
--
4,458.00
Reconciled Depreciation
1,766.00
1,766.00
1,493.00
815.00
1,690.00
Net Income from Continuing Operation Net Minority Interest
-160,276.00
-160,276.00
-137,464.00
-77,329.00
7,028.00
Total Unusual Items Excluding Goodwill
-13,042.00
-13,042.00
-3,881.00
2,396.00
41,209.00
Total Unusual Items
-13,042.00
-13,042.00
-3,881.00
2,396.00
41,209.00
Normalized EBITDA
-136,083.00
-136,083.00
-93,723.00
-84,784.00
-31,607.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-39.13
-39.13
-815.01
406.84
11,126.43
12/31/2020 - 6/7/1996
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

AQST Aquestive Therapeutics, Inc.
4.1050
-8.78%
 
ITCI Intra-Cellular Therapies, Inc.
72.37
+0.51%
 
EGRX Eagle Pharmaceuticals, Inc.
4.6100
+2.90%
 
ESPR Esperion Therapeutics, Inc.
1.9500
+4.28%
 
ALKS Alkermes plc
23.85
+0.38%
 
IRWD Ironwood Pharmaceuticals, Inc.
7.92
+4.21%
 
PCRX Pacira BioSciences, Inc.
26.25
+0.57%
 
EOLS Evolus, Inc.
11.53
-0.26%
 
AYTU Aytu BioPharma, Inc.
2.7900
0.00%
 
ANIP ANI Pharmaceuticals, Inc.
65.48
+1.39%